ALNY — ALNYLAM PHARMACEUTICALS INC

Ownership history in TrinityPoint Wealth, LLC  ·  1 quarter on record

This page tracks every 13F SEC filing in which TrinityPoint Wealth, LLC reported a position in ALNYLAM PHARMACEUTICALS INC (ALNY). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.03% (2024 Q3)
Avg. % of fund
0.03%
First filed
2024 Q3
Last filed
2024 Q3
Quarters held
1
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2024 Q3 INITIATED 728 — — 0.03% $200K $275.03
% of Fund (quarterly)    ALNY price (monthly, adj. close)

Other funds also holding ALNY

As of 2025 Q4 — sorted by position size

FengHe Fund Management Pte. Ltd. 3Y 4.9% Bellevue Group AG 3Y 7Y 3.36% ROSENBLUM SILVERMAN SUTTON S F INC /CA 3Y 7Y 3.05% Orbis Allan Gray Ltd 3Y 7Y 2.7% 683 Capital Management, LLC 3Y 7Y 2.44% Avidity Partners Management LP 3Y 2.41% ORBIMED ADVISORS LLC 3Y 7Y 2.34% Polymer Capital Management (HK) LTD 2.08% Casdin Capital, LLC 3Y 7Y 1.85% Parkman Healthcare Partners LLC 3Y 1.81%
← Back to TrinityPoint Wealth, LLC Holdings